Found 99 matching trials
Anlotinib Hydrochloride Capsules Combined With TQB2450 Injection in Esophageal Squamous Cell Carcinoma Patients PHASE2 This is an Open, Single Arm, Exploratory and Phase II Clinical Trial of Anl...
Show More Location
Jiangxi Cancer Hospital
Learn More & Join Trial
Anlotinib Hydrochloride Combined With Sintilimab Injection in the Treatment of Advanced Hepatocellular Carcinoma (HCC) PHASE2 This is a single-arm, open-label and exploratory clinical study of Anlotini...
Show More Location
Jiangsu Province Hospital
Learn More & Join Trial
TQB2450 Plus Anlotinib as Adjuvant Therapy in HCC Patients at High Risk of Recurrence After Resection PHASE2 This is An Open, Single Arm, Multicenter, Exploratory Phase II study, to ev...
Show More Location
Hunan Provincial People's Hospital (The First Affiliated Hospital of Hunan Normal University)
Learn More & Join Trial
Study of Anlotinib Hydrochloride Capsule Combined With Chemotherapy in Subjects With Squamous Non-small Cell Lung Cancer PHASE3 Anlotinib hydrochloride is a multi-targeted receptor tyrosine kinase inhibi...
Show More Location
Cancer Hospital Chinese Academy of Medical Sciences
Learn More & Join Trial
A Study of Anlotinib Hydrochloride Capsule Combined With AK105 Injection in Subject With Advanced Gastric and Gastro-oesophageal Junction Adenocarcinoma PHASE3 This is a randomized, controlled, open-label, multicenter study to evaluate...
Show More Location
The First Affiliated Hospital of Anhui Medical University
Learn More & Join Trial
Study of Anlotinib in Patients With Radioiodine Refractory Differentiated Thyroid Cancer NA This study aims to observe and explore the efficacy and safety of Anlotinib...
Show More Learn More & Join Trial
A Phase Ib Study of TQB2450 Combined With Anlotinib in Patients With Limited Stage Small Cell Lung Cancer After First-line Radiotherapy and Chemotherapy PHASE1 To assess the efficacy and safety of TQB2450 in combination with anlotinib ...
Show More Location
Cancer Hospital Affiliated to Shandong First Medical University
Learn More & Join Trial
Anlotinib Combined With Dose-dense Temozolomide for the First Recurrent or Progressive Glioblastoma After STUPP Regimen PHASE2 Currently,6 cycles of Temozolomide adjuvant chemotherapy after concurrent r...
Show More Location
Sun Yat-sen University Cancer Center
Learn More & Join Trial
Anlotinib Single Drug as the Maintenance Treatment for Advanced NSCLC NA Based on the need of clinical practice of maintenance therapy for advanced ...
Show More Location
First Hospital of Jilin University
Learn More & Join Trial
Novel Treatment of Advanced Hepatocellular Carcinoma PHASE3 The purpose of this study is to evaluate the efficacy and safety of arginin...
Show More Location
The First Affiliated Hospital of Zhengzhou University
Learn More & Join Trial